Efficacy and safety of first-line chemotherapies for patients with advanced pancreatic ductal adenocarcinoma: A systematic review and network meta-analysis

Efficacy and safety of first-line chemotherapies for patients with advanced pancreatic ductal adenocarcinoma: A systematic review and network meta-analysis

Background: Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, often diagnosed at an advanced stage. Systemic chemotherapy is the primary treatment, but direct comparisons of different regimens are limited. This study conducted a systematic review and network meta-analysis (NMA) to compare...

Full description

Bibliographic Details
Main Authors: Mao-Ji Kang, Hao-Xin Li, Yu Gan, Cheng Fang, Xiao-Li Yang, Bo Li, Song Su
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Heliyon
Subjects:
PDAC
Chemotherapy comparison
NMA
Efficacy
Adverse events
Phase III RCTs
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024037101

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024037101

Similar Items